Quantcast

FDA approves Teva’s Sabril generic version; says making generic drugs competitive is key part to reduce drug cost

Announcing the approval of Teva’s Sabril generic tablets, FDA Commissioner, Scott Gottlieb said that prioritizing the approval of generic drugs to compete with medicines that face little or no competition is the Agency’s key part of efforts to support access and reduce drug costs to patients.

Read more